264 related articles for article (PubMed ID: 12196880)
21. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour.
Ng PS; Chan AS; Sin WK; Tang LC; Cheung KB; Yuen PM
Hum Reprod; 2001 Jan; 16(1):31-35. PubMed ID: 11139532
[TBL] [Abstract][Full Text] [Related]
22. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery.
Gerstenfeld TS; Wing DA
Am J Obstet Gynecol; 2001 Oct; 185(4):878-82. PubMed ID: 11641670
[TBL] [Abstract][Full Text] [Related]
23. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
24. Misoprostol and oxytocin versus oxytocin alone in the active management of the third stage of labour: a randomised, double-blind, placebo-controlled trial.
Ottun TA; Adewunmi AA; Rabiu AK; Olumodeji AM; Oladipo OM; Olalere HF
J Obstet Gynaecol; 2022 Jul; 42(5):1048-1053. PubMed ID: 34958620
[TBL] [Abstract][Full Text] [Related]
25. Misoprostol versus oxytocin in the third stage of labor.
Kundodyiwa TW; Majoko F; Rusakaniko S
Int J Gynaecol Obstet; 2001 Dec; 75(3):235-41. PubMed ID: 11728483
[TBL] [Abstract][Full Text] [Related]
26. Oral misoprostol versus oxytocin in the management of the third stage of labour.
Parsons SM; Walley RL; Crane JMG; Matthews K; Hutchens D
J Obstet Gynaecol Can; 2006 Jan; 28(1):20-26. PubMed ID: 16533451
[TBL] [Abstract][Full Text] [Related]
27. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour.
Oboro VO; Tabowei TO
J Obstet Gynaecol; 2003 Jan; 23(1):13-6. PubMed ID: 12623474
[TBL] [Abstract][Full Text] [Related]
28. Carbetocin versus rectal misoprostol for management of third stage of labor among women with low risk of postpartum hemorrhage.
Maged AM; Waly M; Fahmy RM; Dieb AS; Essam A; Salah NM; Hussein EA; Nabil H
Int J Gynaecol Obstet; 2020 Feb; 148(2):238-242. PubMed ID: 31736069
[TBL] [Abstract][Full Text] [Related]
29. Misoprostol use during the third stage of labor.
Joy SD; Sanchez-Ramos L; Kaunitz AM
Int J Gynaecol Obstet; 2003 Aug; 82(2):143-52. PubMed ID: 12873774
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
Westhoff G; Cotter AM; Tolosa JE
Cochrane Database Syst Rev; 2013 Oct; (10):CD001808. PubMed ID: 24173606
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of misoprostol versus oxytocin for the prevention of postpartum hemorrhage.
Rajaei M; Karimi S; Shahboodaghi Z; Mahboobi H; Khorgoei T; Rajaei F
J Pregnancy; 2014; 2014():713879. PubMed ID: 24734184
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effect of breast pump stimulation and oxytocin administration on the length of the third stage of labor, postpartum hemorrhage, and anemia: a randomized controlled trial.
Dashtinejad E; Abedi P; Afshari P
BMC Pregnancy Childbirth; 2018 Jul; 18(1):293. PubMed ID: 29981576
[TBL] [Abstract][Full Text] [Related]
33. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
34. The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.
Mitchell GG; Elbourne DR
Online J Curr Clin Trials; 1993 Aug; Doc No 83():[2305 words; 32 paragraphs]. PubMed ID: 8306013
[TBL] [Abstract][Full Text] [Related]
35. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.
Ng PS; Lai CY; Sahota DS; Yuen PM
Gynecol Obstet Invest; 2007; 63(1):55-60. PubMed ID: 16940738
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandins for prevention of postpartum haemorrhage.
Gülmezoglu AM; Forna F; Villar J; Hofmeyr GJ
Cochrane Database Syst Rev; 2004; (1):CD000494. PubMed ID: 14973959
[TBL] [Abstract][Full Text] [Related]
37. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic misoprostol for the prevention of postpartum hemorrhage: a randomized controlled trial.
Uncu Y; Karahasan M; Uyaniklar Ö; Uncu G
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):15-22. PubMed ID: 25635970
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandins for prevention of postpartum haemorrhage.
Gülmezoglu AM; Forna F; Villar J; Hofmeyr GJ
Cochrane Database Syst Rev; 2001; (4):CD000494. PubMed ID: 11687083
[TBL] [Abstract][Full Text] [Related]
40. A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour.
Choy CM; Lau WC; Tam WH; Yuen PM
BJOG; 2002 Feb; 109(2):173-7. PubMed ID: 11905429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
